Efficacy and Safety of Lithium for Suicide and Suicide-Related Behaviors in Youth: A Review of the Literature

• Published in: Brain sciences 2024-11, Vol.14 (11), p.1139
• Main Authors: Sesso, Gianluca, Bargnesi, Francesca, Olzi, Francesca, Mutti, Giulia, Berloffa, Stefano, Viglione, Valentina, Fantozzi, Pamela, Tolomei, Greta, Guccione, Fulvio, Milone, Annarita, Masi, Gabriele
• Format: Article
• Language: English
• Subjects: adolescents; Analysis; Antidepressants; Behavior; Bibliographic literature; Bipolar disorder; Case reports; Child psychopathology; Clinical trials; Comorbidity; Cross-sectional studies; Drug dosages; Emotional disorders; Evidence-based medicine; Impulsivity; Literature reviews; Lithium; Mania; Medical research; Medicine, Experimental; Mood; Mood disorders; Pediatrics; Prevention; Review; Self destructive behavior; Self-injury; Suicidal behavior; Suicidal ideation; Suicide; Suicides & suicide attempts; Systematic review; Teenagers; Youth
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci14111139

This systematic review evaluates the anti-suicidal properties of Lithium in children and adolescents with Bipolar Disorder (BD), addressing gaps in evidence regarding its efficacy and safety in reducing suicidality and self-harming behaviors. A comprehensive literature search was conducted across PubMed, Web of Science, and Scopus up to February 2024. Eligible studies were those focusing on patients aged 25 years or younger, examining Lithium therapy and its impact on suicidal ideation and behaviors. The review included randomized controlled trials, longitudinal prospective and retrospective studies, and cross-sectional studies, while excluding expert opinions and case reports. Evidence generally supports the efficacy of Lithium in reducing suicidal ideation and self-harming behaviors in youth with BD, though results are mixed. Randomized controlled trials demonstrated its effectiveness in mitigating suicidal thoughts during acute manic episodes, with effects persisting post-treatment. Longitudinal studies suggested that Lithium might offer superior outcomes compared to other mood stabilizers, although its specific impact on suicidality remains inconclusive. Cross-sectional studies and retrospective analyses reveal associations between Lithium use and reduced self-harming behaviors, but causality remains uncertain. While mood-stabilizing effects of Lithium offer potential benefits for reducing suicidality in youth, evidence on its direct impact on emotional dysregulation (ED) and long-term efficacy is limited. Variability in individual responses and adherence issues underscore the need for further research. Future studies should include larger, diverse samples, focus on ED symptoms, and explore Lithium mechanisms in suicidality prevention. Lithium remains a promising treatment for mood stabilization and reduction in suicidality in youth with BD.